支气管哮喘冷哮急性发作期应用平喘汤治疗的临床观察.docVIP

支气管哮喘冷哮急性发作期应用平喘汤治疗的临床观察 　　[摘要] 目的 分析研究支气管哮喘（冷哮）急性发作期使用平喘汤进行治疗的治疗效果以及意义。 方法 随机选取2013年2月―2014年2月该院收治的70例支气管哮喘（冷哮）急性发作期患者资料进行回顾性分析，将70例患者随机分为两组，观察组和对照组各35例，对照组患者使用常规西医治疗方式加以治疗，观察组患者在常规治疗基础之上使用平喘汤进行治疗，比较两组患者的治疗有效率以及免疫球蛋白、最大呼气流量以及外周血嗜酸性粒细胞情况。 结果 观察组患者的治疗总有效率显著优于对照组患者（P0.05），差异有统计学意义。观察组患者的临床指标，包括免疫球蛋白、最大呼气流量以及外周血嗜酸性粒细胞显著优于对照组患者（P0.05），差异有统计学意义。 结论 针对支气管哮喘（冷哮）急性发作期使用平喘汤加以治疗，治疗效果显著，使患者的生活质量获得显著提高，安全性相对较高，应该在临床中加以推广使用。 　　[关键词] 平喘汤；支气管哮喘；急性发作期 　　[中图分类号] R562.2 [文献标识码] A [文章编号] 1674-0742（2015）09（c）-0152-02 　　[Abstract] Objective To study effect of pingchuan decoction in the treatment of acute bronchial asthma （cold type asthma） and its significance. Methods The clinical data of 70 patients with bronchial asthma （cold type ashma） in acute attack period between February 2013 and February 2014 were retrospectively analyzed. They were divided into observation group and control group with 35 in each group. Patients in the control group were treated with conventional western medicine， while those in the observation group received pingchuan decoction on the basis of the medicine used in the control group. The effective rate， immunoglobulin， maximal expiratory flow and peripheral blood eosinophils were compared between the two groups. Results The total effective rate was higher in the observation group than in the control group with statistically significant difference， P0.05. The clinical indexes， including the levels of immunoglobulin， maximal expiratory flow and peripheral blood eosinophils were all better in the observation group than in the control group， and the difference were statistically significant， P0.05. Conclusion Pingchuan decoction is worthy of promotion in the treatment of acute bronchial asthma （cold type asthma） due to its good effect， higher safety and its ability in improving patients’ quality of life. 　　[Key words] Pingchuan decoction； Bronchial asthma； Acute episode 　　支气管哮喘属于比较多见的一类呼吸系统疾病，是由多类炎性细胞导致的慢性气道炎性病变，最近几年以来，支气管哮喘的发病趋势越来越高，西医治疗主要为解痉平喘，具有显著的治疗效